Federated Journals
  • Home
  • About
Log in Write Now
Log in Subscribe
  • Home
  • About

k kumar

Hi I'm k kumar
171 posts

Non-Small Cell Lung Cancer Market: Emerging Therapies, Trends, and Revenue Outlook

Oncology investors and drug developers alike are keeping a close eye on the NSCLC therapeutics market, as non-small cell lung cancer (NSCLC) — responsible for roughly 85% of all lung cancer

  • Go to the profile of  k kumar
k kumar
23 Aug 2026 · 3 min read

Heart Pump Devices Industry Market Report: Size, Trends, Drivers, and Growth Forecast 2025–2032

Advanced mechanical circulatory support is reshaping how the world treats end-stage heart failure, and the heart pump devices market stands at the center of that shift. Fueled by an aging

  • Go to the profile of  k kumar
k kumar
21 Aug 2026 · 3 min read

Medical Device Contract Manufacturing Market: Growth Analysis and Industry Outlook

Healthcare innovation is moving faster than most device makers can build factories for, and that gap is exactly why the medical device contract manufacturing industry has become such a critical

  • Go to the profile of  k kumar
k kumar
21 Aug 2026 · 3 min read

Global Heart Failure Treatment Market: Emerging Therapies, Market Trends, and Forecast

Global demand for cardiovascular care continues to climb, and the heart failure market size is projected to grow steadily through 2034 as new drug classes reach patients and disease detection

  • Go to the profile of  k kumar
k kumar
20 Aug 2026 · 3 min read

Netherton Syndrome Therapeutics Market: Emerging Drugs and Future Growth Trends

For decades, netherton syndrome has remained a rare disease without a single disease-modifying option. That is starting to change. A wave of clinical-stage candidates, growing regulatory support, and improved diagnostic

  • Go to the profile of  k kumar
k kumar
20 Aug 2026 · 3 min read

Non-Small Cell Lung Cancer Incidence: Prevalence, Trends, and Epidemiological Overview

When clinicians and researchers talk about non-small cell lung cancer epidemiology, they are describing the largest slice of the lung cancer landscape. Non small cell lung carcinoma, commonly shortened to

  • Go to the profile of  k kumar
k kumar
19 Aug 2026 · 3 min read

PCSK9 Inhibitors Market Assessment: Epidemiology, Market Performance, and Forecast to 2034

Before looking at specific brands, it helps to understand pcsk9 inhibitor mechanism of action. PCSK9 is a liver enzyme that latches onto LDL receptors and sends them for degradation, which

  • Go to the profile of  k kumar
k kumar
19 Aug 2026 · 3 min read

Prediabetes Market Research: Epidemiology Insights, Emerging Treatments, and Future Growth

Prediabetes has quietly become one of the most consequential public health challenges of our time, touching over a third of adults in the United States and more than a fifth

  • Go to the profile of  k kumar
k kumar
18 Aug 2026 · 3 min read

Systemic Lupus Erythematosus Market Landscape: Therapeutic Innovation, Pipeline Progress, and Future Growth

Lupus continues to be one of the most complex autoimmune diseases to manage, and its therapeutic landscape is shifting fast. As diagnostic tools improve and a wave of novel mechanisms

  • Go to the profile of  k kumar
k kumar
18 Aug 2026 · 3 min read

Hemophilia Market Landscape: Current Trends, Pipeline Therapies, and Growth Potential

The hemophilia treatment market is entering a pivotal decade, shaped by novel non-factor drugs, gene therapy breakthroughs, and a steadily expanding diagnosed patient base. Within the broader hemophilia market, the

  • Go to the profile of  k kumar
k kumar
18 Aug 2026 · 3 min read

Expert Strategic Insights for Healthcare and Life Sciences Business Growth

Healthcare and life sciences organizations are operating in markets where scientific innovation, competitive activity, regulatory changes, and commercial priorities are constantly evolving. In this environment, access to accurate information is

  • Go to the profile of  k kumar
k kumar
17 Aug 2026 · 7 min read

GLP-1 Agonists Market Evolution: Pipeline Innovation, Growth Potential, and Competitive Landscape

Few therapeutic classes have transformed metabolic medicine as dramatically as GLP-1 agonists. Once used mainly to manage blood sugar in type 2 diabetes, this drug class has expanded into obesity

  • Go to the profile of  k kumar
k kumar
11 Aug 2026 · 3 min read

Coxsackievirus Infections Market Forecast 2032: Trends, Insights, and Epidemiology

Coxsackievirus infections represent a critical challenge in global infectious disease management, affecting millions of individuals annually with manifestations ranging from mild febrile illness to severe complications such as viral myocarditis,

  • Go to the profile of  k kumar
k kumar
11 Aug 2026 · 4 min read

Automated Suturing Devices Market Poised for Strong Growth Through 2030 Amid Rising Surgical Demand

The global anastomosis devices market is on a strong growth trajectory, expected to rise from USD 4,159.35 million in 2025 to USD 6,922.84 million by 2034,

  • Go to the profile of  k kumar
k kumar
10 Aug 2026 · 3 min read

Transforming Medical Congress Data Into Actionable Pharma and Healthcare Intelligence

Medical and healthcare conferences are no longer simply venues for networking and scientific presentations. They have become important sources of clinical, competitive, and commercial intelligence. New trial findings, pipeline updates,

  • Go to the profile of  k kumar
k kumar
10 Aug 2026 · 6 min read

Alport Syndrome Treatment Market Outlook: Innovations Shaping the Future

The alport syndrome market is entering a pivotal decade. Valued at roughly USD 27 million across the US, EU4, UK, and Japan in 2025, this space is projected to expand

  • Go to the profile of  k kumar
k kumar
3 Aug 2026 · 3 min read

Global Autosomal Dominant Polycystic Kidney Disease Market Expected to Expand by 2036

The autosomal dominant polycystic kidney disease market is entering a pivotal decade. Better imaging, wider genetic testing, and growing physician awareness are catching more cases earlier, while a thin pipeline

  • Go to the profile of  k kumar
k kumar
3 Aug 2026 · 3 min read

Fucosidosis Disease Market Insights: Current Landscape and Future Opportunities to 2032

Fucosidosis is a rare, inherited lysosomal storage disorder caused by a deficiency of the enzyme alpha-L-fucosidase, leading to the abnormal accumulation of fucose-containing compounds in the body's tissues. Because the

  • Go to the profile of  k kumar
k kumar
2 Aug 2026 · 3 min read
Federated Journals
© 2026 Federated Journals. All rights reserved.
Design with by @GodoFredoNinja
No results found
    ↑ ↓ Navigate up/down
    Enter Go to article
    Esc Close search